170 related articles for article (PubMed ID: 413937)
1. The effect of intravesical thio-tepa on normal and tumor urothelium.
Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
[TBL] [Abstract][Full Text] [Related]
2. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
Nieh PT; Daly JJ; Irwin RJ; Prout GR
Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
Nocks BN; Nieh PT; Prout GR
J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
Mukamel E; Zitron S; Nissenkorn I; Servadio C
Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
[TBL] [Abstract][Full Text] [Related]
5. Treatment of superficial bladder tumors in a controlled trial with thio-TEPA versus adriamycin.
Horn Y; Eidelman A; Walach N; Yuval E; Markowitz A
J Surg Oncol; 1984 Sep; 27(1):67-9. PubMed ID: 6434883
[TBL] [Abstract][Full Text] [Related]
6. Morphologic effects of thio-TEPA on mouse urothelium.
Murphy WM; Soloway MS; Lin CJ
Acta Cytol; 1977; 21(5):701-4. PubMed ID: 414498
[TBL] [Abstract][Full Text] [Related]
7. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
Horn Y; Eidelman A; Walach N; Ilian M
J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
[No Abstract] [Full Text] [Related]
8. A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
Hirao Y; Okajima E; Ozono S; Samma S; Sasaki K; Hiramatsu T; Babaya K; Watanabe S; Maruyama Y
Cancer Chemother Pharmacol; 1992; 30 Suppl():S26-30. PubMed ID: 1394812
[TBL] [Abstract][Full Text] [Related]
9. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
Dobrzecki W; Kaczmarek A
Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
[TBL] [Abstract][Full Text] [Related]
10. Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells.
Murphy WM; Soloway MS; Lin CJ
Acta Cytol; 1978; 22(6):550-4. PubMed ID: 104512
[TBL] [Abstract][Full Text] [Related]
11. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.
Brosman SA
J Urol; 1982 Jul; 128(1):27-30. PubMed ID: 6809960
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
Wescott JW
J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
[No Abstract] [Full Text] [Related]
13. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
[No Abstract] [Full Text] [Related]
14. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
[TBL] [Abstract][Full Text] [Related]
15. Anticancer drug sensitivity in vitro in the bladder cancer cell line, KK-47 and prophylactic use of carbazilquinone and urokinase in bladder cancer.
Hisazumi H; Uchibayashi T; Katoh M; Kobayashi T; Nakajima K; Naitoh K; Misaki T; Kuroda K
Urol Res; 1981; 9(5):231-5. PubMed ID: 7029855
[TBL] [Abstract][Full Text] [Related]
16. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
[TBL] [Abstract][Full Text] [Related]
17. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
[TBL] [Abstract][Full Text] [Related]
18. The role of cystography in thio-tepa toxicity.
Orlin I
J Urol; 1972 Aug; 108(2):257-8. PubMed ID: 4625850
[No Abstract] [Full Text] [Related]
19. Thiotepa effects on urinary cytology in the interpretation of transitional cell cancer.
Droller MJ; Erozan YS
J Urol; 1985 Oct; 134(4):671-4. PubMed ID: 3928906
[TBL] [Abstract][Full Text] [Related]
20. 32p-labeled thio-tepa absorption in normal rat bladders: potential guide for intravesical chemotherapy in bladder cancer.
Puchner PJ; Veenema RJ; Tomashefsky P; Pinzus T; Tannenbaum T
Urology; 1974 Jul; 4(1):33-6. PubMed ID: 21322979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
